IP Library Assignment 056342/0830
Patent Assignment
Reel/Frame 056342/0830

Assignment of Assignor's Interest

Recorded: 2021-05-25 Pages: 4
Assignors
LEE, TIEN
Executed: 2016-04-22
KLINGEMANN, HANS G.
Executed: 2016-04-22
SIMON, BARRY J.
Executed: 2016-03-30
BOISSEL, LAURENT
Executed: 2016-04-22
Assignee
NANTKWEST, INC.
9920 JEFFERSON BLVD., CULVER CITY, CALIFORNIA, 90232
Covered Property (1)
Genetically Modified Nk-92 Cells and Monoclonal Antibodies for the Treatment of Cancer
Application: 17/217,839 →
Publication: US 2021/0236550
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Aug 2, 2021
From: NANTKWEST, INC.
To: IMMUNITYBIO, INC.
Reel/Frame 057059/0802 →
Assignment of Assignor's Interest Oct 23, 2023
From: CAMPBELL, KERRY
To: INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER
Reel/Frame 065304/0975 →
Security Interest Jan 2, 2024
From: IMMUNITYBIO, INC.; NANTCELL, INC.; RECEPTOME, INC.; VBC HOLDINGS LLC
To: INFINITY SA LLC, AS PURCHASER AGENT
Reel/Frame 066179/0074 →